Supplement 

Proceedings from 'Clinical Audit in Retina 2017'

This supplement and the meeting on which it was based were sponsored by Novartis. All authors received honoraria, contributed to the development of the manuscript, and retained final control of the content and editorial decisions. Medical writing assistance was provided by Sue Lupton of Novartis. Novartis have checked that the content was factually accurate, balanced and compliant with the Association of the British Pharmaceutical Industry Code of Practice.

Clinical Audit in Retina 2017

Crowne Plaza, Birmingham City Centre, UK

Wednesday 28th June 2017

Chairman: Ms Bushra Mushtaq

Organizer: Novartis Pharmaceuticals UK